Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Net Equity Issued and Repurchased (2013 - 2015)

Bausch Health Companies (BHC) posted Net Equity Issued and Repurchased of -$700000.0 for Q4 2015, down 100.05% sequentially from $1.4 billion in Q1 2015.

Bausch Health Companies (BHC) Net Equity Issued and Repurchased (2013 - 2015) Analysis & Trends

Bausch Health Companies has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at -$700000.0 in Q4 2015.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$700000.0 in Q4 2015, while the trailing twelve-month figure through Sep 2016 was -$700000.0 (down 100.05% YoY) and the FY2015 annual result came in at $1.4 billion, changed N/A from the prior year.
  • Net Equity Issued and Repurchased retreated to -$700000.0 in Q4 2015 per BHC's latest filing, from $1.4 billion in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $2.3 billion in Q2 2013 and troughed at -$1.3 million in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 -700,000.00
Dec 31, 2015 -700,000.00
Mar 31, 2015 1.43 Bn
Mar 31, 2015 1.43 Bn
Dec 31, 2013 37.50 Mn
Dec 31, 2013 37.50 Mn
Sep 30, 2013 -1.30 Mn
Sep 30, 2013 -1.30 Mn
Jun 30, 2013 2.27 Bn
Jun 30, 2013 2.27 Bn